Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Invasive breast carcinoma - IARC
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
serous and transitional cell <strong>carcinoma</strong><br />
and endometrioid and clear cell.<br />
Grading<br />
The least diff e rentiated component<br />
determines the tumour grade.<br />
Histogenesis<br />
Endometriosis, occasionally with atypia,<br />
is found in association with 53% of MEBT<br />
{2496} and up to 50% of mixed clear cellendometrioid<br />
tumours {2511}. Some<br />
cases show a transition from endometriosis<br />
to neoplastic epithelium.<br />
Somatic genetics<br />
It is impossible to make broad statements,<br />
as studies are limited to a few<br />
cases. LOH on chromosome 17, common<br />
in serous tumours, has been found<br />
in two of five mixed endometrioid-serous<br />
tumours {959}. PTEN mutation, which has<br />
been associated with the endometrioid<br />
type, has also been noted in a mixed<br />
mucinous-endometrioid tumour {2075}.<br />
KRAS mutations, an early event in mucinous<br />
tumours, have been noted in three<br />
mixed Brenner-mucinous tumours {589}.<br />
The mucinous cystadeno<strong>carcinoma</strong> and<br />
B renner tumour components share d<br />
amplification of 12q 14-21 in one MET,<br />
suggesting clonal relatedness {2207}.<br />
Prognosis and predictive factors<br />
The behaviour of MEBT is similar to that of<br />
endocervical-like mucinous bord e r l i n e<br />
tumours. The dominant cell type generally<br />
dictates behaviour. An exception is<br />
mixed endometrioid and serous <strong>carcinoma</strong>,<br />
which, even when the serous component<br />
is minor, behaves more aggressively<br />
than pure endometrioid <strong>carcinoma</strong><br />
and similarly to their serous counterpart.<br />
Mixed endometrioid and serous carc i n o-<br />
ma may recur as serous carc i n o m a<br />
{2907}. This finding stresses the importance<br />
of careful sampling of an<br />
endometrioid cystadeno<strong>carcinoma</strong> to rule<br />
out a mixed serous component.<br />
Undifferentiated <strong>carcinoma</strong><br />
D e f i n i t i o n<br />
A primary ovarian <strong>carcinoma</strong> with no diff<br />
e rentiation or only small foci of diff e re n t i-<br />
ation.<br />
ICD-O code 8 0 2 0 / 3<br />
E p i d e m i o l o g y<br />
When applying the WHO criteria, appro x-<br />
imately 4-5% of ovarian cancers are undiff<br />
e rentiated <strong>carcinoma</strong>. The frequency of<br />
u n d i ff e rentiated <strong>carcinoma</strong> was 4.1%<br />
when defined as <strong>carcinoma</strong>s with solid<br />
a reas as the predominant component re p-<br />
resenting over 50% of the tumour {2677}.<br />
Clinical features<br />
In the only large series the age of the<br />
patients ranged from 39-72 (mean, 54<br />
years) {2677}.<br />
M a c r o s c o p y<br />
M a c ro s c o p i c a l l y, undiff e rentiated carc i n o-<br />
ma does not have specific features. The<br />
tumours are predominantly solid, usually<br />
with extensive areas of necrosis.<br />
Tumour spread and staging<br />
A c c o rding to FIGO, 6% of the patients are<br />
d i s c o v e red in stage I, 3% are in stage II,<br />
74% in stage III and 17% in stage IV; thus<br />
91% of the tumours are discovered in<br />
stages III and IV {2677}.<br />
H i s t o p a t h o l o g y<br />
H i s t o l o g i c a l l y, undiff e rentiated carc i n o m a<br />
consists of solid groups of tumour cells<br />
with numerous mitotic figures and significant<br />
cytological atypia. Areas with a spindle<br />
cell component, microcystic pattern<br />
and focal vascular invasion can be seen.<br />
It is unusual to see an undiff e re n t i a t e d<br />
c a rcinoma without any other component<br />
of müllerian <strong>carcinoma</strong>. Usually, areas of<br />
high grade serous <strong>carcinoma</strong> are pre s e n t .<br />
Foci of transitional cell <strong>carcinoma</strong> can<br />
also be seen. Undiff e rentiated carc i n o m a<br />
of the ovary does not have a specific<br />
i m m u n o p h e n o t y p e .<br />
D i ff e rential diagnosis<br />
The main diff e rential diagnoses are granulosa<br />
cell tumour of the adult type, transitional<br />
cell <strong>carcinoma</strong>, poorly diff e re n t i a t e d<br />
squamous cell <strong>carcinoma</strong>, small cell <strong>carcinoma</strong><br />
and metastatic undiff e re n t i a t e d<br />
c a rcinoma.<br />
Granulosa cell tumours may have a diffuse<br />
pattern; however, it is unusual not to<br />
have also areas with a trabecular pattern ,<br />
Call-Exner bodies or areas showing sex<br />
c o rds. In addition, undiff e rentiated carc i-<br />
noma is a more anaplastic tumour with a<br />
larger number of mitotic figures.<br />
Transitional cell <strong>carcinoma</strong>s might have<br />
a reas of undiff e rentiated tumour; however,<br />
either a trabecular pattern or large papillae<br />
are always identified in the form e r.<br />
Small cell <strong>carcinoma</strong> of the hyperc a l-<br />
caemic type typically occurs in young<br />
women and often contains follicle-like<br />
s t r u c t u res. The cells of small cell carc i n o-<br />
ma of the pulmonary type show nuclear<br />
molding and have high nuclear to cytoplasmic<br />
ratios.<br />
F i n a l l y, metastatic undiff e rentiated carc i-<br />
nomas are uniform tumours without papill<br />
a ry areas.<br />
All these diff e rential diagnoses can usually<br />
be resolved when the tumour is well<br />
sampled, and areas with a diff e re n t<br />
m a c roscopic appearance are submitted.<br />
Sampling will identify the diff e rent components<br />
of the tumour that are characteristic<br />
of primary ovarian lesions.<br />
Prognosis and predictive factors<br />
The five-year survival of patients with<br />
u n d i ff e rentiated <strong>carcinoma</strong> is worse than<br />
that of ovarian serous or transitional cell<br />
c a rcinoma. Only 6% of these patients survive<br />
for 5 years.<br />
Unclassified adeno<strong>carcinoma</strong><br />
D e f i n i t i o n<br />
A primary ovarian adeno<strong>carcinoma</strong> that<br />
cannot be classified as one of the specific<br />
types of müllerian adenocarc i n o m a<br />
because it has overlapping features or is<br />
not sufficiently diff e rentiated. These<br />
tumours are uncommon.<br />
ICD-O code 8 1 4 0 / 3<br />
H i s t o p a t h o l o g y<br />
Tumours in this category would include<br />
well or moderately diff e rentiated tumours<br />
with overlapping features such as a mucinous<br />
tumour with cilia, or it might include<br />
a less diff e rentiated tumour without distinctive<br />
features of one of the mûllerian<br />
types of adenocarcoma.<br />
Prognosis and predictive factors<br />
Since this group of tumours has not yet<br />
been specifically studied, the prognosis is<br />
not known.<br />
Surface epithelial-stromal tumours 145